NervGen Pharma (9UA.F) Q4 2025 Earnings

25NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.08
-0.07
-0.05
-0.04

Details

Expected EPS
-0.0527708101
Actual EPS
-0.0372499836
Surprise EPS
0.02
Surprise Percent
+29.41%

Description

NervGen Pharma (9UA.F) has reported earnings of -0.0372499836 per share for Q4 2025.

0 Comments

Share your thoughts